Venture capital for medical technology harder to come by: report

CHICAGO (Reuters) - Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures for...

Source: http://feeds.reuters.com/~r/news/wealth/~3/v_tciZ4hIPs/us-medtech-investing-idUSBRE89104D20121002

gus dahleh housing recovery short sale approval refinancing